Our vision is to offer better protection to patients during acute, severe and life-threatening medical conditions by an effective, user-friendly, safe and immediately active powder-based Intranasal specialized products.
Board of directors
Co-Founder & Executive Chairman
Dr. Dalia Megiddo - CEO
Co-founder & Board Member
Dr. Ronnie Hershman
Galia Temtsin Kryaz, Ph.D.
Director of Product Development
Tair Lapidot, Ph.D
VP R&D and Clinical Development
Director of Finance
Commercial & Marketing Director
MIQUEL MARTI JUVANTENY
Director of Business Development
Senior Director of RA & QA
Prof Yuval Tal
Prof Regina Scherließ
David M. Fleischer, MD
Nasus pharma brings the new frontier in Intranasal drug delivery. Late-Stage Specialty Pharma company, offers Powder-Based Intranasal (PBI) specialized product portfolio, to address acute medical conditions and public health threats.